230 related articles for article (PubMed ID: 23249575)
1. [Targeted based therapies in metastatic breast cancer: future evolution].
Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
[TBL] [Abstract][Full Text] [Related]
2. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
Greillier L; Barlesi F
Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
[No Abstract] [Full Text] [Related]
3. The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
Johnston SR
Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023
[TBL] [Abstract][Full Text] [Related]
4. The next generation of biologic agents: therapeutic role in relation to existing therapies in metastatic breast cancer.
Conte P; Guarneri V
Clin Breast Cancer; 2012 Jun; 12(3):157-66. PubMed ID: 22607765
[TBL] [Abstract][Full Text] [Related]
5. Novel agents and future directions for refractory breast cancer.
Burstein HJ
Semin Oncol; 2011 Jun; 38 Suppl 2():S17-24. PubMed ID: 21600381
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging targeted therapies for metastatic breast cancer.
Perez EA; Spano JP
Cancer; 2012 Jun; 118(12):3014-25. PubMed ID: 22006669
[TBL] [Abstract][Full Text] [Related]
7. Introduction: Current and future approaches to chemotherapy in patients with resistant breast cancer.
Burstein HJ
Semin Oncol; 2011 Jun; 38 Suppl 2():S1-2. PubMed ID: 21600379
[No Abstract] [Full Text] [Related]
8. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
Awada A
Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
[TBL] [Abstract][Full Text] [Related]
9. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
10. Chairperson's introduction: Despite significant advances in the diagnosis and treatment of breast cancer, approximately one third of patients still develop, and subsequently die from metastatic breast disease.
Johnston SR
Eur J Cancer; 2011 Sep; 47 Suppl 3():S4-5. PubMed ID: 21944027
[No Abstract] [Full Text] [Related]
11. Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?
Berrada N; Delaloge S; André F
Ann Oncol; 2010 Oct; 21 Suppl 7():vii30-5. PubMed ID: 20943632
[TBL] [Abstract][Full Text] [Related]
12. Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer.
Comen EA
Discov Med; 2012 Aug; 14(75):97-104. PubMed ID: 22935206
[TBL] [Abstract][Full Text] [Related]
13. [Genomics and clinical research for breast cancer].
Bertucci F; Birnbaum D
Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
[TBL] [Abstract][Full Text] [Related]
14. [Major therapeutic advances and new perspectives in onco-hematology].
Bay JO; Guièze R; Ravinet A; Lemal R; Xhaard A; Bailly S; Moluçon-Chabrot C; Hermet E; Biau J; Verrelle P; Peffault de Latour R; Tournilhac O
Bull Cancer; 2013 Jun; 100(6):587-99. PubMed ID: 23735575
[TBL] [Abstract][Full Text] [Related]
15. The role of targeted therapy in ovarian cancer.
Banerjee S; Kaye S
Eur J Cancer; 2011 Sep; 47 Suppl 3():S116-30. PubMed ID: 21943965
[TBL] [Abstract][Full Text] [Related]
16. Personalizing oncology: perspectives and prospects.
Mendelsohn J
J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
[TBL] [Abstract][Full Text] [Related]
17. Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer.
Tkaczuk KH
Clin Ther; 2009; 31 Pt 2():2273-89. PubMed ID: 20110041
[TBL] [Abstract][Full Text] [Related]
18. The evolution of bone-targeted therapies: introduction.
Gnant M
Semin Oncol; 2010 Oct; 37 Suppl 2():S1. PubMed ID: 21111243
[No Abstract] [Full Text] [Related]
19. Awaiting a new era of cancer immunotherapy.
Hong CW; Zeng Q
Cancer Res; 2012 Aug; 72(15):3715-9. PubMed ID: 22815525
[TBL] [Abstract][Full Text] [Related]
20. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
Halterman PA
Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
